Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.

Medistim ASA

ExThera Medical develops blood filtration technologies, specifically the Seraph® 100 Microbind® Affinity Blood Filter for treating severe COVID-19 and the ONCObind™ Extracorporeal Procedure for treating metastatic cancer.

ExThera Medical

Medistim provides technology for transit time flow measurement (TTFM) used in cardiac, vascular, and transplant surgery. The systems combine ultrasound imaging with flow measurement.

Metric
Company Name	Medistim ASA	ExThera Medical
Symbol	0OCD
MSH ID	COM:MEDISTIM	COM:EXTHERAMEDICAL
Market	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Medical - Equipment & Services	Medical Devices
Country	NO	US
Stage
Employee Count	150
Website	medistim.com	extheramedical.com
LinkedIn
Founders

Metric
Market Cap	287.67M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	47.24M
Revenue (LTM)
Revenue (NTM)
Gross Profit	20.45M
EBITDA	13.92M
Operating Income	11.80M
Net Income	9.32M
EPS	0.51
Diluted EPS	0.51
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.59
Operating Profit Margin	0.25
EBITDA Margin	0.29
Net Profit Margin	0.20
Return on Equity	0.27
Return on Assets	0.21
Return on Capital Employed	0.32

COM:MEDISTIM

Medistim

Last Close

133.50

22/11 12:31

Market Cap

3.21B

Beta: -

Volume Today

196

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	33.21
P/B Ratio	10.29
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	6.30
EV Multiple	22.46

Metric
Days Sales Outstanding	56.28
Days Payables Outstanding	120.71
Days Inventory Outstanding	264.89
Operating Cycle	324.42
Cash Conversion Cycle	324.42
Asset Turnover	1.04

Metric
Operating Cash Flow	10.40M
Free Cash Flow	10.40M
Cash Flow to Debt	16.22
Operating Cash Flow/Sales	0.26
Free Cash Flow Yield	0.02

Metric
Cash & Equivalents	13.81M
Accounts Receivable
Inventory	13.05M
Goodwill
Debt to Capitalization	0.04
Debt to Assets
Current Ratio	4.05
Quick Ratio	2.99

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.04
SG&A to Revenue	0.05